 JERUSALEM , May 9, 2022 PRNewswire -- BiondVax Pharmaceuticals Ltd. NASDAQ: BVXV, a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today announced that it will present at the 20th Biomed Israel Conference and Exhibition, to be held May 10-12, 2022, in Tel Aviv, Israel. 